Medicare's Alzheimer's Drug Spending Projection Far Exceeds Reality
Medicare's initial cost estimate for the Alzheimer's drug Leqembi was $3.5 billion for 2025, but new data shows this projection was significantly over...
Medicare's initial cost estimate for the Alzheimer's drug Leqembi was $3.5 billion for 2025, but new data shows this projection was significantly over...
State officials are racing to enforce Medicaid work requirements by 2027, but critical questions remain unanswered. With federal guidance delayed unti...